Metropolitan Life Insurance CO Ardelyx, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$6.05 - $9.74 $8,415 - $13,548	-1,391 Reduced 10.55%	11,793 $86,000
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $2,520 - $5,086	766 Added 6.17%	13,184 $81,000
Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $2,514 - $3,680	762 Added 6.54%	12,418 $50,000
Q2 2023 Aug 10, 2023	BUY	$3.23 - $4.95 $37,648 - $57,697	11,656 New	11,656 $39,000
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $33,213 - $213,661	-26,152 Closed	0 $0
Q2 2021 Jun 21, 2023	BUY	$6.55 - $8.98 $171,295 - $234,844	26,152 New	26,152 $198,000
Q2 2021 Mar 30, 2023	BUY	$6.55 - $8.98 $92,335 - $126,591	14,097 Added 116.94%	26,152 $198,000
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $171,217 - $234,737	26,140 Added 217833.33%	26,152 $198,000
Q1 2021 Jun 26, 2023	BUY	$6.1 - $7.69 $73,535 - $92,702	12,055 New	12,055 $79.8 Million
Q1 2021 Mar 30, 2023	SELL	$6.1 - $7.69 $52,514 - $66,203	-8,609 Reduced 41.66%	12,055 $79,000
Q1 2021 May 14, 2021	SELL	$6.1 - $7.69 $125,977 - $158,813	-20,652 Reduced 99.94%	12 $80,000
Q4 2020 Jun 22, 2023	BUY	$5.05 - $7.1 $104,353 - $146,714	20,664 New	20,664 $133,000
Q4 2020 Mar 30, 2023	SELL	$5.05 - $7.1 $2,247 - $3,159	-445 Reduced 2.11%	20,664 $133,000
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $2,247 - $3,159	-445 Reduced 2.11%	20,664 $134,000
Q3 2020 Jun 26, 2023	BUY	$5.25 - $7.08 $110,822 - $149,451	21,109 New	21,109 $110,000
Q3 2020 Mar 30, 2023	SELL	$5.25 - $7.08 $1,134 - $1,529	-216 Reduced 1.01%	21,109 $110,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $1,134 - $1,529	-216 Reduced 1.01%	21,109 $111,000
Q2 2020 Jun 26, 2023	BUY	$5.37 - $8.11 $114,515 - $172,945	21,325 New	21,325 $147,000
Q2 2020 Mar 30, 2023	BUY	$5.37 - $8.11 $3,383 - $5,109	630 Added 3.04%	21,325 $147,000
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $3,383 - $5,109	630 Added 3.04%	21,325 $148,000
Q1 2020 Jul 12, 2023	BUY	$4.35 - $8.79 $90,023 - $181,909	20,695 New	20,695 $117,000
Q1 2020 Mar 30, 2023	BUY	$4.35 - $8.79 $42,612 - $86,106	9,796 Added 89.88%	20,695 $117,000
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $42,612 - $86,106	9,796 Added 89.88%	20,695 $118,000
Q4 2019 Jul 12, 2023	BUY	$4.23 - $8.29 $46,102 - $90,352	10,899 New	10,899 $81,000
Q4 2019 Mar 30, 2023	SELL	$4.23 - $8.29 $31,255 - $61,254	-7,389 Reduced 40.4%	10,899 $81,000
Q4 2019 Feb 14, 2020	SELL	$4.23 - $8.29 $31,255 - $61,254	-7,389 Reduced 40.4%	10,899 $82,000
Q3 2019 Jul 12, 2023	BUY	$2.15 - $6.28 $39,319 - $114,848	18,288 New	18,288 $85,000
Q3 2019 Mar 30, 2023	BUY	$2.15 - $6.28 $39,319 - $114,848	18,288 New	18,288 $85,000
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $39,319 - $114,848	18,288 New	18,288 $86,000

Others Institutions Holding ARDX

# of Institutions

219

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account